Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05030948 · ClinicalTrials.gov registry record · NA

A Physical Activity Intervention to Promote Cognitive Health, Cardiovascular Health and Sleep in Older Latinos

A NA study of Mild Cognitive Impairment, sponsored by University of Pennsylvania.

Active
Registry status
NA
Development phase
236
Enrollment target
1
Study location

NCT05030948: Active NA study of Mild Cognitive Impairment, sponsored by University of Pennsylvania.

NCT05030948 is a NA study of Mild Cognitive Impairment that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 236 participants, below the 1,269-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05030948, a NA study of Mild Cognitive Impairment, is active but no longer recruiting, sponsored by University of Pennsylvania.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
236 participants
Enrollment target
1
Study location

Study Summary

This study is a randomized, single-blind, controlled trial that will test a multilevel intervention, Tiempo Juntos para la Salud, (Time Together for Health) designed to promote moderate-intensity physical activity; theoretically grounded mediators; and secondary outcomes of cardiovascular health, sleep and cognitive function. Participants will have 4 visits over a year long period. Data collection will occur at baseline, 3 months, 6 months, and 12 months among 216 Spanish language-dominant Latinos aged 55 and older with Mild Cognitive Impairment (MCI) \[Montreal Cognitive Assessment (MoCA) score 23 to 26 for Latino populations\].

Primary Outcome

Number of activity sessions

Conditions Studied

Interventions

  • BEHAVIORAL Tiempo Juntos Intervention

Study Locations (1)

Pennsylvania

  • University of Pennsylvania School of Nursing - Philadelphia

Trial Details

FieldValue
Enrollment Target 236 participants
Start Date 2021-08-27
Est. Completion 2025-12-31
Phase NA
University of Pennsylvania

1,423 total trials

What the registry record for NCT05030948 still lists

NCT05030948 is an interventional study that assigns participants to a tested intervention. The registered 236 participants enrollment target is mid-sized for trials with a published cap, below the 1,269-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (81% lower).

The record links to 1 condition, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which Tiempo Juntos Intervention is the first listed.

NCT05030948 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05030948 about?

NCT05030948 is a clinical study titled "A Physical Activity Intervention to Promote Cognitive Health, Cardiovascular Health and Sleep in Older Latinos". This study is a randomized, single-blind, controlled trial that will test a multilevel intervention, Tiempo Juntos para la Salud, (Time Together for Health) designed to promote moderate-intensity physical activity; theoretically grounded mediators; and secondary outcomes of cardiovascular health, sl...

What is the current status of trial NCT05030948?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 236 participants. The study started on 2021-08-27. Estimated completion is 2025-12-31.

What conditions does trial NCT05030948 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment.

What interventions are being tested in trial NCT05030948?

The interventions under investigation include: Tiempo Juntos Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05030948?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05030948 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05030948's enrollment target sits among peer trials

236 39th of 205 higher than 166 of 205 other Mild Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04995341 · 236 participants · NA

    Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)

  • NCT06200103 · 236 participants · Phase 2

    Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

  • NCT06494072 · 236 participants · Phase 4

    Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP

  • NCT06615557 · 236 participants · Phase 3

    Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05030948, the US trial registry maintained by the National Library of Medicine. NCT05030948 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.